WebOperating Status Active. Last Funding Type Post-IPO Debt. Legal Name Cytokinetics, Inc. Stock Symbol NASDAQ:CYTK. Company Type For Profit. Contact Email [email protected]. Phone Number … WebDescription. Developer of diagnostic therapeutics drug designed to improve the treatment of painful osteoarthritis, back, and joint pain. The company's drug offers a Fibronectin …
Did you know?
WebWho is Cytokinetics Headquarters 350 Oyster Point Blvd, South San Francisco, California, 94080, United States Phone Number (650) 624-3000 Website www.cytokinetics.com Revenue $65M Stock Symbol CYTK Industry Pharmaceuticals Healthcare Cytokinetics's Social Media Is this data correct? View contact profiles from Cytokinetics Popular … WebCytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. Stock Information. Press Releases. In the News. Calendar. …
WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- … Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance … WebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle …
WebCytokinetics Incorporated 280 East Grand Avenue South San Francisco, CA 94080 United States. Website. Investor relation . Ratios; Stock Price Chart; Annual Returns; … WebFeb 28, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential...
Web2 days ago · View Cytokinetics, Incorporated CYTK investment & stock information. Get the latest Cytokinetics, Incorporated CYTK detailed stock quotes, stock data, Real …
WebCytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 80 U.S.-traded ETFs. CYTK has around 18.9M shares in the U.S. ETF market. The largest ETF holder of... north brink breweryWebNov 3, 2024 · Enrollment Complete in Cohort 3 of REDWOOD-HCM; Results Expected in Q1 2024. SOUTH SAN FRANCISCO, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the third quarter of 2024. Net loss for the third quarter was $76.1 million, or $0.95 per share, compared to … north brink onlineWebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … north brink practiceWebMar 24, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... north brink doctors surgery wisbechWebHeadquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX how to report an accident in coloradoWebApr 13, 2024 · Issuer Name and Ticker or Trading Symbol CYTOKINETICS INC [ CYTK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below) Other (specify below) EVP Research & Development: 3. Date of Earliest Transaction (Month/Day/Year) 04/13/2024: 4. ... how to report an amputation to oshaWebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. About the company Rewards Revenue is forecast to grow 46.65% per year Risk Analysis Negative shareholders equity north brink surgery online booking